Chimerix Stock Analysis

Chimerix Stock Analysis Notes

About 46.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.6. Some equities with similar Price to Book (P/B) outperform the market in the long run. Chimerix recorded a loss per share of 0.94. The entity had not issued any dividends in recent years. Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. For more info on Chimerix please contact Michael MBA at 919 806 1074 or go to https://www.chimerix.com.

Chimerix Investment Alerts

Chimerix Upcoming and Recent Events

Chimerix Largest EPS Surprises

View All Earnings Estimates

Chimerix Thematic Classifications

Chimerix Stock Institutional Investors

Note, although Chimerix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Chimerix Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 81.39 M.

Chimerix Profitablity

Management Efficiency

Chimerix has return on total asset (ROA) of (0.3022) % which means that it has lost $0.3022 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4859) %, meaning that it created substantial loss on money invested by shareholders. Chimerix's management efficiency ratios could be used to measure how well Chimerix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.41 in 2024. Return On Capital Employed is likely to drop to -0.5 in 2024. At this time, Chimerix's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 316.1 K in 2024, whereas Total Assets are likely to drop slightly above 197 M in 2024.

Technical Drivers

As of the 29th of November, Chimerix shows the Mean Deviation of 2.44, risk adjusted performance of (0.01), and Standard Deviation of 3.25. Chimerix technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Chimerix Price Movement Analysis

Chimerix Insider Trading Activities

Chimerix Outstanding Bonds

Chimerix Predictive Daily Indicators

Chimerix Forecast Models

Chimerix's time-series forecasting models are one of many Chimerix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chimerix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Chimerix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Chimerix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Chimerix. By using and applying Chimerix Stock analysis, traders can create a robust methodology for identifying Chimerix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Chimerix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Chimerix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Chimerix stock analysis indicators help investors evaluate how Chimerix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Chimerix shares will generate the highest return on investment. By understating and applying Chimerix stock analysis, traders can identify Chimerix position entry and exit signals to maximize returns.

When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.